IONS vs NATL · rev $514.0M vs P/E 19, rev $1.15B
Ionis Pharmaceuticals Inc (IONS) versus NCR Atleos Corporation (NATL) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
NCR Atleos Corporation (NATL) is a software - application company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported NATL revenue for 2025-12-31 was $1.15B. Net income was $83.0M. Revenue was up 4.0% from 2024-12-31 to 2025-12-31. NATL currently screens at market cap $2.17B and trailing P/E 18.8.
IONS currently screens at market cap $12.28B. NATL currently screens at market cap $2.17B and trailing P/E 18.8.
Not investment advice. Open the IONS and NATL stock pages for the full models.
Not investment advice.